APAC peripheral artery disease market report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

APAC Peripheral Artery Disease Market Overview

• The APAC Peripheral Artery Disease market is valued at USD 2.4 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, an aging population, and advancements in medical technology. The rising awareness regarding early diagnosis and treatment options has also contributed significantly to the market's expansion. The region is experiencing a rapid increase in chronic diseases such as diabetes, hypertension, and obesity, which are major risk factors for peripheral artery disease, further accelerating demand for advanced diagnostic and therapeutic devices. Technological innovations, including minimally invasive procedures and the approval of new devices, are reshaping treatment paradigms and expanding patient access across both urban and rural areas.
• Key players in this market include India, China, and Japan, which dominate due to their large populations and increasing healthcare expenditure. India and China are particularly notable for their rapid urbanization and rising incidence of lifestyle-related diseases, while Japan benefits from its advanced healthcare infrastructure and high demand for innovative medical devices. The Asia-Pacific region, with China and India accounting for a significant share of the global population, is witnessing a surge in healthcare budgets and disposable income, which is supporting market expansion.
• The Government of India’s National Health Mission, launched in 2013 and periodically updated, aims to enhance healthcare access and affordability across the country. The mission includes provisions for the prevention, early detection, and management of non-communicable diseases, including peripheral artery disease, through strengthened primary healthcare infrastructure, capacity building, and the provision of essential drugs and diagnostics. Compliance with the mission’s guidelines is mandatory for state health departments, and it supports the adoption of advanced medical technologies in both public and private healthcare settings.

APAC Peripheral Artery Disease Market Segmentation

By Product Type:The product type segmentation includes various devices used in the treatment and management of peripheral artery disease. The subsegments are Peripheral Stents, PTA Balloons and Drug-Eluting Balloons, Atherectomy Devices, Plaque Modification Devices, Catheters and Angiography Catheters, Endovascular Aneurysm Repair (EVAR) Stent Grafts, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, and Peripheral Accessories. Among these, Peripheral Stents are leading the market due to their effectiveness in treating blockages in peripheral arteries, which is a common complication of peripheral artery disease. Plaque Modification Devices are the fastest-growing segment, driven by technological advancements and increasing adoption in complex vascular interventions.

By End-User:The end-user segmentation includes Hospitals, Specialty Clinics and Vascular Centers, and Ambulatory Surgical Centers. Hospitals are the dominant end-user segment due to their comprehensive facilities and resources for treating complex cases of peripheral artery disease. The increasing number of patients seeking treatment in hospitals, coupled with advancements in surgical techniques and technologies, has further solidified their leading position in the market. Ambulatory surgical centers are also experiencing growth, supported by favorable reimbursement policies and the trend toward outpatient care for less complex procedures.

APAC Peripheral Artery Disease Market Competitive Landscape

The APAC Peripheral Artery Disease Market is characterized by a dynamic mix of regional and international players. Leading participants such as Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, Cook Group Incorporated, Terumo Corporation, B. Braun Melsungen AG, Edwards Lifesciences Corporation, Philips Healthcare, Teleflex Incorporated, St. Jude Medical (Abbott), Avinger, Inc., Inari Medical, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

**Market Size Note:** The Asia-Pacific peripheral vascular devices market was valued at approximately USD 2.38 billion in 2023. The peripheral artery disease device segment, a major component of this market, is estimated at approximately USD 2.4 billion, reflecting normalization based on available regional device revenue data. This figure is consistent with the broader device market dynamics in the region and aligns with the growth trajectory driven by demographic and technological factors. **Growth Drivers Update:** The market is further propelled by rising healthcare spending, improved insurance penetration, and government initiatives to modernize healthcare infrastructure. The shift toward minimally invasive treatments and the introduction of novel drug-coated devices and robotic navigation systems are expanding the addressable patient population and improving procedural outcomes. The increasing burden of diabetes and hypertension, coupled with lifestyle changes, continues to elevate the risk profile for peripheral artery disease across APAC, sustaining demand for advanced diagnostic and therapeutic solutions. **Regulation Update:** The National Health Mission (NHM) in India, issued by the Ministry of Health and Family Welfare, Government of India, is the primary framework for non-communicable disease prevention and management, including peripheral artery disease. The NHM mandates the integration of screening, early diagnosis, and management of cardiovascular diseases into primary healthcare services, with compliance required for all state health departments. The mission supports the procurement and deployment of advanced medical devices in public health facilities and promotes public-private partnerships to enhance service delivery.

APAC Peripheral Artery Disease Market Industry Analysis

Growth Drivers

• Increasing Prevalence of Cardiovascular Diseases:The APAC region is witnessing a significant rise in cardiovascular diseases, with an estimated 10 million deaths attributed to these conditions annually. According to the World Health Organization, cardiovascular diseases account for 32% of all global deaths. This alarming trend is driving the demand for effective treatments for peripheral artery disease (PAD), as healthcare systems strive to manage the growing patient population and improve health outcomes through advanced medical interventions.
• Advancements in Medical Technology:The APAC market is benefiting from rapid advancements in medical technology, particularly in the development of innovative devices and procedures for treating PAD. In future, the medical device market in APAC is projected to reach $150 billion, with a significant portion dedicated to cardiovascular devices. These innovations, including drug-eluting stents and minimally invasive surgical techniques, are enhancing treatment efficacy and patient recovery times, thereby driving market growth.
• Rising Geriatric Population:The geriatric population in the APAC region is expected to reach 1 billion in future, according to the United Nations. This demographic shift is crucial as older adults are at a higher risk for developing PAD due to age-related factors. The increasing number of elderly individuals is prompting healthcare providers to focus on preventive measures and effective treatment options for PAD, thereby expanding the market for related medical services and devices.

Market Challenges

• High Treatment Costs:One of the significant challenges facing the APAC PAD market is the high cost of treatment, which can be prohibitive for many patients. For instance, the average cost of a single angioplasty procedure can exceed $20,000 in some countries. This financial burden limits access to necessary treatments, particularly in low-income regions, thereby hindering overall market growth and patient outcomes.
• Limited Access to Healthcare Facilities:Access to healthcare facilities remains a critical challenge in many parts of the APAC region. According to the World Bank, approximately 50% of the population in rural areas lacks access to essential health services. This disparity in healthcare access can lead to delayed diagnoses and treatments for PAD, exacerbating health issues and limiting the effectiveness of available medical interventions.

APAC Peripheral Artery Disease Market Future Outlook

The future of the APAC Peripheral Artery Disease market appears promising, driven by technological advancements and an increasing focus on preventive healthcare. As healthcare systems adapt to the growing prevalence of cardiovascular diseases, the integration of artificial intelligence in diagnostics and treatment planning is expected to enhance patient outcomes. Furthermore, the shift towards personalized medicine will likely lead to more effective treatment strategies tailored to individual patient needs, fostering a more proactive approach to managing PAD.

Market Opportunities

• Expansion of Telemedicine:The rise of telemedicine presents a significant opportunity for the PAD market, particularly in remote areas. With an estimated 30% of patients preferring virtual consultations, healthcare providers can leverage telehealth to improve access to specialists and enhance patient engagement, ultimately leading to better management of PAD.
• Development of Innovative Treatment Options:There is a growing opportunity for the development of innovative treatment options, such as gene therapy and advanced drug delivery systems. With an investment of over $5 billion in research and development in the APAC region, these innovations can significantly improve treatment efficacy and patient outcomes, addressing the unmet needs in PAD management.